Ca 21 mobilization from intracellular stores represents an important cell signalling process 1 that is regulated, in mammalian cells, by inositol-1,4,5-trisphosphate (InsP 3 ), cyclic ADP ribose and nicotinic acid adenine dinucleotide phosphate (NAADP). InsP 3 and cyclic ADP ribose cause the release of Ca 21 from sarcoplasmic/endoplasmic reticulum stores by the activation of InsP 3 and ryanodine receptors (InsP 3 Rs and RyRs). In contrast, the nature of the intracellular stores targeted by NAADP and the molecular identity of the NAADP receptors remain controversial 1,2 , although evidence indicates that NAADP mobilizes Ca 21 from lysosome-related acidic compartments 3,4 . Here we show that two-pore channels (TPCs) comprise a family of NAADP receptors, with human TPC1 (also known as TPCN1) and chicken TPC3 (TPCN3) being expressed on endosomal membranes, and human TPC2 (TPCN2) on lysosomal membranes when expressed in HEK293 cells. Membranes enriched with TPC2 show high affinity NAADP binding, and TPC2 underpins NAADPinduced Ca 21 release from lysosome-related stores that is subsequently amplified by Ca 21 -induced Ca 21 release by InsP 3 Rs. Responses to NAADP were abolished by disrupting the lysosomal proton gradient and by ablating TPC2 expression, but were only attenuated by depleting endoplasmic reticulum Ca 21 stores or by blocking InsP 3 Rs. Thus, TPCs form NAADP receptors that release Ca 21 from acidic organelles, which can trigger further Ca 21 signals via sarcoplasmic/endoplasmic reticulum. TPCs therefore provide new insights into the regulation and organization of Ca 21 signals in animal cells, and will advance our understanding of the physiological role of NAADP.
non-allelic TPC genes are present in sea urchins and most vertebrate species, with TPC3 absent in most primates and some rodent species ( Supplementary Fig. 2 ). The three TPCs are equally distant from each other, and from plant TPC1, with ,30% amino acid identity in the conserved transmembrane regions ( Fig. 1b and Supplementary  Fig. 2 ). Although Arabidopsis TPC1 has been shown to mediate Ca 21 release from plant intracellular vacuoles 21 , functional data are lacking for animal TPCs.
Similar to the reported widespread expression of TPC1 messenger RNA 19 , northern analysis shows that human TPC2 mRNA is expressed in most human tissues, with higher levels in the liver and kidneys (Fig. 1c ). Immunofluorescence labelling of HEK293 cells using an anti-TPC2 antibody (see Supplementary Fig. 3 ) showed punctate staining in the cytoplasm, which was blocked by the antigenic peptides (data not shown) and overlaps with that of lysosomemembrane associated protein 2 (LAMP2; Fig. 1d , Pearson's coefficient 5 0.92). Similarly, in a stable cell line expressing haemagglutinin (HA)-tagged TPC2 (hereafter termed TPC2 cells), the HAtagged protein colocalizes with LAMP2 ( Fig. 1e , Supplementary Movie 1, Supplementary Table 1 , and Supplementary Fig. 4 ) but not with markers for early and late endosomes, or with markers for ER, Golgi or mitochondria ( Supplementary Fig. 5a-e ). Moreover, LysoTracker (Fig. 1f ), but not MitoTracker or fluorescent transferrin (data not shown), accumulated in intracellular vesicles surrounded by HA-TPC2. Similar results were obtained for heterologously expressed mouse TPC2 ( Supplementary Fig. 6 ).
In contrast, heterologously expressed TPC1 and TPC3 show only sparse colocalization with TPC2 or LAMP2, and are instead predominantly expressed in endosomes and other unidentified intracellular compartments (Supplementary Figs 5f, g, 7 and Supplementary  Table 1 ). Therefore, all mammalian TPCs are expressed intracellularly on endolysosomes, with TPC2 being specifically targeted to lysosomal membranes.
The lysosomal localization and homology to Ca 21 channels prompted us to test whether TPC2 forms a binding site for NAADP. Membranes from the TPC2 and wild-type HEK293 cells were incubated with 0.2 nM [ 32 P]NAADP in the absence and presence of unlabelled NAADP (100 mM). TPC2 membranes showed more than a threefold increase in specific binding compared to wild-type membranes ( Fig. 2a ). To confirm that the binding is associated with expressed TPC2 proteins, we depleted HA-TPC2 from the membranes using an anti-HA antibody, and tested [ 32 P]NAADP binding to the resulting supernatant and pellet. With the anti-HA antibody the binding was mainly associated with the pellet, whereas with a control antibody it remained in the supernatant (Fig. 2b) .
A ligand competition assay showed that the TPC2-containing membranes had two affinities to NAADP with dissociation constant (K d ) values of 5.0 6 4.2 nM (mean 6 s.e.m.) and 7.2 6 0.8 mM (n 5 3) ( Fig. 2c ). This binding curve closely resembles that of mouse liver membranes ( Fig. 2d ), which had affinity values of 6.6 6 3.5 nM and 4.6 6 2.4 mM (n 5 4), and these K d values for the high affinity binding site compare well with results reported for other mammalian preparations [22] [23] [24] .
As expected 22, 25 , NADP-the precursor of NAADP that is unable to mobilize Ca 21 -only showed low-affinity binding to TPC2 and mouse liver membranes, with K d values of 10.3 6 3.1 mM (n 5 3) and 4.5 6 2.3 mM (n 5 4), respectively. This could also arise from contamination by trace amounts of NAADP in NADP preparations 5 . Moreover, although wild-type membranes showed specific binding to NAADP, the ligand competition assay could only reveal low affinity binding, indicating that the fraction for high affinity binding must be very low. This is supported by quantitative PCR with reverse transcription (qRT-PCR) which showed a .250-fold increase in TPC2 mRNA in TPC2 cells compared to wild-type cells (Supplementary Information). Therefore, TPC2 expression confers the high affinity NAADP binding. Although we cannot exclude the possibility that interactions with accessory proteins may be necessary for NAADP binding to TPC2, such proteins would have to associate with TPC2 tightly to explain these binding results.
To test whether TPC2 mediates Ca 21 release from lysosomes, we studied the effect of flash photolysis of caged NAADP on intracellular Ca 21 concentration ([Ca 21 ] i ) in wild-type HEK293 and TPC2 cells by Fluo3 fluorescence. As shown in part a of Fig. 3A , all TPC2 cells responded to photorelease of NAADP with a biphasic [Ca 21 ] i transient comprising an initial slow pacemaker-like ramp (10-180 s) and a subsequent large Ca 21 transient. No fluorescence increase occurred after ultraviolet flashes if caged NAADP was not included (n 5 6, data not shown). Furthermore, wild-type cells showed only small and short-lived [Ca 21 ] i rises, and lacked both the ramp-like phase and the secondary transient ( Fig. 3B ).
Consistent with a role for lysosomes in this process, the vacuolar H 1 -ATPase inhibitor bafilomycin A1 (1 mM) abolished both phases of the response to NAADP (see d in Fig. 3A ), but failed to affect the [Ca 21 ] i rise induced by extracellular application of 100 mM ATP, which activates ER Ca 21 release (data not shown). In contrast, inclusion of heparin (200 mg ml 21 ), a competitive inhibitor of InsP 3 Rs, in the patch pipette only blocked the secondary phase of the Ca 21 transient and thereby revealed in its entirety the initial [Ca 21 ] i signal triggered by NAADP (see b in Fig. 3A) . Consistent with the lack of RyR expression in HEK293 cells 26 , both phases of the response to photorelease of NAADP persisted in TPC2 cells preincubated with 10 mM ryanodine (data not shown). Furthermore, the combined effects of depleting the ER store by pretreatment with thapsigargin (1 mM), blocking InsP 3 Rs with heparin and RyRs with ryanodine caused no further inhibition of the NAADP-induced response than blocking InsP 3 Rs with heparin alone (Fig. 3A, c, and C) . Therefore, the initial [Ca 21 ] i rise is dependent on acidic organelles but independent of the ER, whereas the secondary phase is due to ER Ca 21 release by InsP 3 Rs, presumably through Ca 21 -induced Ca 21 release together with resting InsP 3 levels.
To determine the concentration-response relationship for NAADP, we dialysed known concentrations of NAADP into single cells using patch pipettes, and monitored [Ca 21 ] i changes using Fura2 (refs 13,18) . In TPC2 cells, whereas 100 pM NAADP did not cause any appreciable [Ca 21 ] i rise, 10 nM NAADP elicited a biphasic response reminiscent of that evoked by the photolysis of caged NAADP (a and b in Fig. 3D ). Pretreatment with thapsigargin abolished the second but not the first phase (c in Fig. 3D ). The response was also seen with 1 mM NAADP but not with much higher concentrations (1 mM; Fig. 3F ), consistent with the notion that NAADP-induced Ca 21 release desensitizes at high ligand concentrations 6 . In contrast, 10 nM NAADP had no effect in wild-type cells, and 1 mM only induced a small, perhaps more localized, Ca 21 transient in three out of five cells (Fig. 3E, F) .
Again, the Ca 21 transient induced by intracellular dialysis of 10 nM NAADP in TPC2 cells was blocked by bafilomycin. More importantly, the response was abolished by transfection into TPC2 cells of a short hairpin RNA (shRNA) against human TPC2 ( Supplementary Fig. 8 ), but not that of a scrambled control shRNA (Fig. 3F) , demonstrating the essential role of TPC2 in mediating NAADP-induced Ca 21 release. All cells responded to extracellularly applied carbachol, which triggers ER Ca 21 release, indicating that the cells were viable 27 .
To examine the role of endogenous TPC2 in NAADP signalling in a native system, we generated Tpc2 knockout mice using a gene trap strategy (Fig. 4a-c and Supplementary Information) 28 and isolated pancreatic b-cells in which previous studies have established that NAADP-dependent Ca 21 mobilization from a thapsigargin-insensitive acidic store 12, 24 underpins the gating of a Ca 21 -activated plasma membrane cation current. Figure 4d shows that under the whole-cell configuration, intracellular dialysis of 100 nM NAADP elicited oscillatory inward currents in wild-type b-cells held at 270 mV. No such currents were detected if NAADP was omitted from the pipette solution, if intracellular Ca 21 was strongly buffered by 10 mM BAPTA, or if the extracellular cations were replaced by N-methyl-D-glucamine (data not shown). Notably, NAADP failed to activate the cation currents in b-cells from the Tpc2 knockout mice (Fig. 4e) , strongly suggesting that TPC2 has a critical role in native NAADP-evoked Ca 21 signalling in b-cells.
These results are best explained if TPC2 is a lysosomal Ca 21 release channel targeted by NAADP. Although we have focused on TPC2 because of its predominant lysosomal localization, TPC1 and TPC3 may also mediate NAADP-induced Ca 21 release from distinct subsets of acidic organelles, such as the distinguished endosome populations suggested by their subcellular distributions. Indeed, we have observed significant but highly localized Ca 21 transients in response to 10 nM NAADP in cells that overexpress human TPC1 as opposed to the global [Ca 21 ] i changes seen in TPC2 cells ( Supplementary Fig.  9 and Supplementary Movie 2). This distinction is consistent with the more restricted subcellular distribution of TPC1 compared to TPC2 ( Supplementary Fig. 7) .
The biphasic Ca 21 response to NAADP in TPC2-overexpressing cells, and the dependence of the later phase on InsP 3 Rs and the ER are consistent with the idea that NAADP-induced Ca 21 signals are small, and perhaps localized, but able to act, at least via TPC2, as discrete triggers for large global [Ca 21 ] i changes through coupling to InsP 3 R/ RyR-S/ER systems. This adds an intriguing possibility for signal diversification, given that the pure NAADP-evoked Ca 21 signal is small and highly localized once the ER Ca 21 store is depleted by thapsigargin (as shown in parts c of Fig. 3A and D) for heterologously expressed TPC2 as well as the endogenous channels in the human hepatoblastoma cell line HepG2 ( Supplementary Fig. 10 ). However, the localized Ca 21 signals will probably reach high levels, particularly at lysosome-ER junctions with unheralded versatility supplied by the fact that TPC-containing vesicles undergo rapid movement within the cytoplasm (Supplementary Movie 3). In this respect it is important to note that NAADP-sensitive Ca 21 signals can have several coupling targets. In sea urchin eggs and pancreatic acinar cells, NAADP-induced Ca 21 signals are coupled to ER Ca 21 release through InsP 3 Rs and RyRs 6, 11, 29 ; in pulmonary arterial smooth muscle cells, they seem to selectively target RyRs 13, 18 ; in pancreatic b-cells, they are coupled to Ca 21 -activated cation channels. Thus, the graded local and mobile endolysosome-derived Ca 21 signals released via TPCs, through coupling to other systems, are dynamic and versatile. Future investigations on the role of TPCs as NAADP receptors will therefore provide important advances in our understanding of the mechanisms of regulation, spatial organization and diverse functional roles of Ca 21 signals in mammalian cells.
METHODS SUMMARY
The complementary DNA for human TPC2 was cloned from HEK293 cells by RACE-PCR. Northern hybridization was performed using a multi-tissue human mRNA blot (BD Biosciences). For stable expression, the amino-terminal HAtagged TPC2 was placed in pIRESneo (BD Biosciences), transfected in HEK293 cells, and stable clones were selected and maintained using G418. [ 32 P]NAADP synthesis, membrane purification and radioligand binding studies were carried out as previously described 23, 25 . Caged NAADP was synthesized as described 30 . Tpc2 knockout mice were developed from an embryonic stem cell line (YHD437) containing a gene trap mutation in the Tpc2 gene. Details for flash photolysis of caged NAADP, intracellular NAADP dialysis, Ca 21 imaging, and measurement of Ca 21 -activated cation currents are described in Methods.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
